ERBB2 and glioblastoma: When assessed using primary GBM cells (n = 3) with variable HER2 and PD-L1 expressions (Supplementary Fig. S3D), CAR28ζ cells expressing a CPR28monomer demonstrated greater killing of autologous tumor cells compared with CPR28dimer (n = 3; Fig. 2D).